屈光手术后眼痛:发生频率与危险因素的中期分析
这项前瞻性研究纳入两个中心的109例接受屈光手术者(87% LASIK,13% PRK),术后6个月随访显示11%报告持续性眼痛(NRS≥3分且3个月和6个月均如此)。多变量分析显示术前眼痛、术前抑郁症状、术前口服抗过敏药和术后第1天疼痛强度可预测持续性眼痛,眼表泪液功能异常体征与眼痛无显著关联。
要点
- 屈光手术后11%报告持续性眼痛(NRS≥3分且3个月和6个月均如此)。
- 术前眼痛(OR 1.87)、术前抑郁症状(OR 1.3)、术前口服抗过敏药(OR 13.6)和术后第1天疼痛强度(OR 1.6)预测持续性眼痛。
- 眼表泪液功能异常体征与眼痛无显著关联(P>0.05),超过90%对视力满意。
核心结论
- 11%的个体在屈光手术后报告持续性眼痛,若干术前和围手术期因素可预测术后疼痛。
研究设计与样本
- 前瞻性研究,纳入两个中心接受屈光手术的109例个体,其中87%接受LASIK、13%接受PRK。
- 术前及术后1天、3个月、6个月用0-10分数字评定量表(NRS)评估眼痛,术后3个月和6个月进行聚焦眼表健康的临床检查。
- 持续性眼痛定义为术后3个月和6个月NRS评分均≥3分(患者组),并与两个时间点NRS评分均<3分的个体(对照组)比较。
主要发现
- 109例接受屈光手术的患者术后随访6个月,平均年龄34±8岁(范围23-57岁),62%自认为女性,81%自认为白人,33%自认为西班牙裔。
- 术前8例(7%)报告眼痛(NRS评分≥3分),术后眼痛频率升至3个月时23%(n=25)和6个月时24%(n=26)。
- 12例(11%)在两个时间点均报告NRS评分≥3分,构成持续性眼痛组。
- 多变量分析中预测术后持续性疼痛的因素为:术前眼痛预测术后持续性疼痛(OR 1.87;95%CI 1.06-3.31);术前抑郁症状报告(患者健康问卷-9:OR 1.3;95%CI 1.1-1.6;P=0.01);术前使用口服抗过敏药(OR 13.6;95%CI 2.1-89.3;P=0.007);术后第1天疼痛强度(OR 1.6;95%CI 1.2-2.2;P=0.005)。
- 眼表泪液功能异常体征与眼痛之间无显著关联,所有眼表体征的P>0.05。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To examine the frequency and risk factors for ocular pain after laser assisted in situ keratomileusis (LASIK) and photorefractive keratectomy (PRK). DESIGN: Prospective study of individuals undergoing refractive surgery at 2 different centers. PARTICIPANTS: One hundred nine individuals undergoing refractive surgery: 87% LASIK and 13% PRK. METHODS: Participants rated ocular pain on a numerical rating scale (NRS) of 0 to 10 before surgery and 1 day, 3 months, and 6 months after surgery. A clinical examination focused on ocular surface health was performed 3 and 6 months after surgery. Persistent ocular pain was defined as an NRS score of 3 or more at both 3 and 6 months after surgery (patients), and this group was compared with individuals with NRS scores of < 3 at both time points (control participants). MAIN OUTCOME MEASURES: Individuals with persistent ocular pain after refractive surgery. RESULTS: The 109 patients who underwent refractive surgery were followed up for 6 months after surgery. Mean age was 34 ± 8 years (range, 23-57 years); 62% self-identified as female, 81% as White, and 33% as Hispanic. Eight patients (7%) reported ocular pain (NRS score ≥ 3) before surgery, with the frequency of ocular pain increasing after surgery to 23% (n = 25) at 3 months and 24% (n = 26) at 6 months. Twelve patients (11%) reported an NRS score of 3 or more at both time points and constituted the persistent pain group. Factors that predicted persistent pain after surgery in a multivariable analysis were (1) ocular pain before surgery predicated persistent pain after surgery (odds ratio [OR], 1.87; 95% confidence interval [CI], 1.06-3.31), (2) symptom report of depression before surgery (Patient Health Questionnaire-9: OR, 1.3; 95% CI, 1.1-1.6; P = 0.01), (3) use of an oral antiallergy medication before surgery (OR, 13.6; 95% CI, 2.1-89.3; P = 0.007), and (4) pain intensity day 1 after surgery (OR, 1.6; 95% CI, 1.2-2.2; P = 0.005). There were no significant associations between ocular surface signs of tear dysfunction and ocular pain, P > 0.05 for all ocular surface signs. Most individuals (> 90%) were completely or somewhat satisfied with their vision at 3 and 6 months. CONCLUSIONS: Eleven percent of individuals reported persistent ocular pain after refractive surgery, with several preoperative and perioperative factors predicting pain after surgery. FINANCIAL DISCLOSURE(S): Proprietary or commercial disclosure may be found after the references.
引用
- Betz J, Behrens H, Harkness BM, et al. Ocular Pain after Refractive Surgery: Interim Analysis of Frequency and Risk Factors. Ophthalmology. 2023. PMID: 36809816. doi:10.1016/j.ophtha.2023.02.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。